Connect with us

News

Nigerian govt will back NAFDAC on Covid-19 researches –Ehanire

Published

on

The Federal Government has stated that it will support the National Agency for Food and Drug Administration Control (NAFDAC) on researches for a vaccine for the novel Covid-19 disease.

This was revealed on Thursday by Osagie Ehanire, Nigeria’s Health Minister, while he was speaking at the Presidential Task Force on COVID-19 joint briefing on Thursday in Abuja.

According to Ehanire, who revealed Nigeria’s virtual participation in a World Health Organization (WHO), African Regional Conference centered on COVID-19 vaccines, the Federal Government will sustain interest in vaccine development and liaise with countries and organizations investing in new knowledge.

He said; “NAFDAC is trying to reach the maturity level to assure that the processes and product that come out of research work in Nigeria are realizable and that they meet the required standard.

READ ALSO: Church, mosque gatherings still risk for spread of COVID-19 –Ehanire

“Our safest, easiest and cheapest option of achieving a balance between saving livelihood and saving lives remains adherence to non-pharmaceutical measures, as we have preached so many times.”

This came days after Ehanire, said that the Federal Government had started working with global health and research organisations developing COVID-19 vaccines.

Ehanire also added that the government had been holding talks with the organisations for the allocation of two billion vaccine doses whenever they are available.

Join the conversation

Opinions

Support Ripples Nigeria, hold up solutions journalism

Balanced, fearless journalism driven by data comes at huge financial costs.

As a media platform, we hold leadership accountable and will not trade the right to press freedom and free speech for a piece of cake.

If you like what we do, and are ready to uphold solutions journalism, kindly donate to the Ripples Nigeria cause.

Your support would help to ensure that citizens and institutions continue to have free access to credible and reliable information for societal development.

Donate Now